weight loss medication
‘Concerning’: Low levels of contraception alongside GLP-1 use
Off-label use of GLP-1s among women of reproductive age has skyrocketed since 2020, with researchers concerned about its potential impact on unintended pregnancies Community pharmacists have an opportunity to counsel …
Weight loss: which medications are evolving as class leaders?
In recent times, pharmacists have been besieged by patients requesting medications for weight loss. How do these medications work and what is their place in weight management? By Karalyn Huxhagen …
Complementary and alternative medicines for weight reduction
The complementary and alternative medicine (CAM) sector of the weight loss market often receives poor press because of the lack of scientific evidence underpinning products. Pharmacists can be implicated in …
‘I’ve seen lots of patients doing that’
People are “microdosing” weight loss drugs mainly due to cost or availability… a pharmacist and a GP who see this frequently share how they respond People are “microdosing” weight loss …
A weighty issue
Overweight and obesity are a big problem in Australia. How can pharmacists help to tackle it and reduce the burden of disease? Sheshtyn Paola investigates KEY POINTS: Two in three …
Expert insights on the pharmacological management of overweight and obesity
This webinar aims to provide pharmacists with a comprehensive understanding of overweight and obesity, including its prevalence, health consequences, diagnosis and management. Gain expert knowledge from Professor John Dixon on …
Ozempic shortage pain to continue until year’s end
TGA underscores ‘limited availability’ means drug should still only be prescribed for type-2 diabetes There will be continued “limited availability” of diabetes drug Ozempic until 31 December 2023 due to …
Innovation needed in weight-loss medications
Shortages of diabetes medication, Ozempic (semaglutide), fueled by off-label prescribing of it as a weight-loss treatment, highlight the need for new drugs to tackle obesity. With supplier, Novo Nordisk …
Banned for 12 months
A Sydney doctor whose prescribing of compounded stimulants to at-risk patients was described as ‘reprehensible’ has been struck off the register, while a compounding pharmacist will front the tribunal A …
Medication can help in fight against obesity
Systematic review and meta-analysis involving 30,000 patients reveals success of weight loss agents The review published in JAMA looked at five medications approved for management of obesity in the US: orlistat, …